Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| adipocyte | 5 studies | 31% ± 15% | |
| epithelial cell | 3 studies | 31% ± 11% |
Insufficient scRNA-seq data for expression of LPIN3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 2517.33 | 21 / 21 | 98% | 20.12 | 493 / 504 |
| esophagus | 99% | 3456.32 | 1436 / 1445 | 98% | 19.88 | 180 / 183 |
| kidney | 100% | 4959.00 | 89 / 89 | 98% | 26.73 | 880 / 901 |
| intestine | 99% | 3879.86 | 961 / 966 | 98% | 22.48 | 516 / 527 |
| pancreas | 100% | 1734.67 | 327 / 328 | 97% | 17.10 | 172 / 178 |
| ovary | 100% | 2719.55 | 180 / 180 | 96% | 16.97 | 412 / 430 |
| stomach | 99% | 1952.60 | 355 / 359 | 96% | 22.50 | 275 / 286 |
| breast | 100% | 3945.26 | 459 / 459 | 93% | 13.01 | 1044 / 1118 |
| lung | 97% | 1885.35 | 558 / 578 | 96% | 17.04 | 1111 / 1155 |
| thymus | 100% | 5842.37 | 653 / 653 | 91% | 13.09 | 551 / 605 |
| uterus | 99% | 3831.44 | 169 / 170 | 90% | 15.38 | 413 / 459 |
| prostate | 100% | 3946.71 | 245 / 245 | 86% | 9.32 | 434 / 502 |
| skin | 100% | 5517.79 | 1809 / 1809 | 85% | 12.66 | 400 / 472 |
| liver | 96% | 2851.14 | 217 / 226 | 78% | 9.47 | 316 / 406 |
| adrenal gland | 92% | 1362.95 | 237 / 258 | 56% | 5.98 | 128 / 230 |
| adipose | 100% | 3516.64 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 2534.29 | 1323 / 1335 | 0% | 0 | 0 / 0 |
| heart | 96% | 1914.06 | 826 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 95% | 10.14 | 76 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 12.40 | 42 / 45 |
| spleen | 86% | 1019.46 | 208 / 241 | 0% | 0 | 0 / 0 |
| brain | 14% | 126.97 | 375 / 2642 | 12% | 1.43 | 88 / 705 |
| muscle | 11% | 92.93 | 88 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.33 | 2 / 29 |
| peripheral blood | 1% | 10.17 | 12 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0019432 | Biological process | triglyceride biosynthetic process |
| GO_0032869 | Biological process | cellular response to insulin stimulus |
| GO_0009062 | Biological process | fatty acid catabolic process |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0005634 | Cellular component | nucleus |
| GO_0008195 | Molecular function | phosphatidate phosphatase activity |
| GO_0003713 | Molecular function | transcription coactivator activity |
| Gene name | LPIN3 |
| Protein name | Lipin 3 Phosphatidate phosphatase LPIN3 (EC 3.1.3.4) (Lipin-3) (Lipin-3-like) |
| Synonyms | LIPN3L |
| Description | FUNCTION: Magnesium-dependent phosphatidate phosphatase enzyme which catalyzes the conversion of phosphatidic acid to diacylglycerol during triglyceride, phosphatidylcholine and phosphatidylethanolamine biosynthesis therefore regulates fatty acid metabolism. . |
| Accessions | ENST00000373257.8 [Q9BQK8-1] Q9BQK8 ENST00000445975.1 H0Y5E1 ENST00000632009.1 [Q9BQK8-2] |